http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31827352

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 24452
issn 1944-8244
1944-8252
issueIdentifier 21
pageRange 24442-24452
publicationName ACS Applied Materials & Interfaces
startingPage 24442
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_12e2d3ec52d611d75cdccb5e01c19c09
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d3fc806d556442cca07360e09220bd7c
bibliographicCitation Zhang Y, Chen Y, Li J, Zhu X, Liu Y, Wang X, Wang H, Yao Y, Gao Y, Chen Z. Development of Toll-like Receptor Agonist-Loaded Nanoparticles as Precision Immunotherapy for Reprogramming Tumor-Associated Macrophages. ACS Appl Mater Interfaces. 2021 Jun 02;13(21):24442–52. doi: 10.1021/acsami.1c01453. PMID: 34008947.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b2bc2dd1f641026d5febc150a503736e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9137fe389d3788dfc8786b5f58f9a09a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b57d539050e175e5e3b855ad5ac56ee
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ffa78ed8be3c6865e711df54a4e3732d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_de8c9e0a4ecf57e7ddc1634f26d9ab41
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2093-4639
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8cc6bf3dd0f13f4c52754ebfc8072f32
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43332d5ae97dea4b1dca84c3bf728b95
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d266a33891ab33d62809ad611bee439d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4542d47814b7621efa7ce508ebfbe1a1
date 2021-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1021/acsami.1c01453
https://pubmed.ncbi.nlm.nih.gov/34008947
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/36564
https://portal.issn.org/resource/ISSN/1944-8252
https://portal.issn.org/resource/ISSN/1944-8244
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Development of Toll-like Receptor Agonist-Loaded Nanoparticles as Precision Immunotherapy for Reprogramming Tumor-Associated Macrophages
discusses http://id.nlm.nih.gov/mesh/M0286281
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000084582Q000276
http://id.nlm.nih.gov/mesh/D007167Q000379
http://id.nlm.nih.gov/mesh/D051193Q000819
http://id.nlm.nih.gov/mesh/D053758
http://id.nlm.nih.gov/mesh/D057285
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D051379

Total number of triples: 41.